Description

Squalane is derived by hydrogenation of squalene. It is naturally present in the skin lipid barrier of plants, animals and humans, preventing moisture loss while restoring skin’s suppleness and flexibility. In contrast to squalene, due to the complete saturation of squalane, it is not subject to auto-oxidation. This fact, coupled with lower costs associated with squalane, make it desirable in cosmetic applications. Squalene is a high-end, oil-free moisturizing ingredient used in many cosmetics that, until recently, was extracted primarily from the liver of deep sea sharks. Squalene is quickly absorbed into the skin without leaving an oily residue and also mixes well with other oils, which will augment its demand in personal care and cosmetic products. Squalene is also used in the manufacture of vaccines. The squalane market in China, in terms of revenue, is expected to grow by 8.7 percent annually through 2028, according to data and analytics company StrategyHelix.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for squalane. The China squalane market is segmented on the basis of product, and application. By product, the squalane market in China has been segmented into animal-based squalane, biosynthetic squalane, plant-derived squalane. Based upon application, the squalane market in China is categorized into cosmetics, dietary supplements, pharmaceuticals, others.

The China squalane market is highly competitive. The squalane market is dominated by key players, which are Amyris Inc., Arbee Biomarine Extracts Pvt. Ltd., Efp Biotek, Kishimoto Special Liver Oil Co. Ltd., Maruha Nichiro Corporation, Nucelis LLC, Sophim S.A., Vestan SA, Yichun Dahaigui Life Science Co. Ltd. Competitive landscape gives a description of the competitive nature of the squalane market in China and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the squalane market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Product: animal-based squalane, biosynthetic squalane, plant-derived squalane
Application: cosmetics, dietary supplements, pharmaceuticals, others
Years considered: this report covers the period 2018 to 2028
Company mentioned: Amyris Inc., Arbee Biomarine Extracts Pvt. Ltd., Efp Biotek, Kishimoto Special Liver Oil Co. Ltd., Maruha Nichiro Corporation, Nucelis LLC, Sophim S.A., Vestan SA, Yichun Dahaigui Life Science Co. Ltd.

Key Benefits for Stakeholders

– Get a comprehensive picture of the China squalane market
– Identify regional strategies and strategic priorities on the basis of local data
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Squalane market overview
Part 3. Market breakdown by product
– Animal-based squalane
– Biosynthetic squalane
– Plant-derived squalane
Part 4. Market breakdown by application
– Cosmetics
– Dietary supplements
– Pharmaceuticals
– Others
Part 5. Key companies
– Amyris, Inc.
– Arbee Biomarine Extracts Pvt. Ltd.
– Efp Biotek
– Kishimoto Special Liver Oil Co., Ltd.
– Maruha Nichiro Corporation
– Nucelis LLC
– Sophim S.A.
– Vestan SA
– Yichun Dahaigui Life Science Co., Ltd.
About StrategyHelix
Disclaimer